Literature DB >> 14632728

TOP2A and HER-2 gene amplification in fine needle aspirates from breast carcinomas.

A M Bofin1, B Ytterhus, B M Hagmar.   

Abstract

The TOP2A gene is located on chromosome 17 close to the HER-2 gene. It encodes an enzyme involved in the regulation of cell proliferation. Using fluorescence in situ hybridization (FISH), we have examined fine needle aspiration smears from 42 cases of breast carcinoma with probes for TOP2A, HER-2 and chromosome 17. We found that amplification of TOP2A is a frequent finding in breast cancer and is often but not exclusively accompanied by HER-2 gene amplification. It is associated with high histological grade and oestrogen receptor (ER) negativity. TOP2A deletions may also be associated with high histological grade and loss of ER. TOP2A amplification in the absence of HER-2 amplification may be associated with lower histological grade and ER positivity. Testing for TOP2A aberrations may be useful in the search for individually tailored treatment regimes for breast cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14632728     DOI: 10.1046/j.0956-5507.2003.00088.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  11 in total

1.  Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.

Authors:  Michael F Press; Guido Sauter; Marc Buyse; Leslie Bernstein; Roberta Guzman; Angela Santiago; Ivonne E Villalobos; Wolfgang Eiermann; Tadeusz Pienkowski; Miguel Martin; Nicholas Robert; John Crown; Valerie Bee; Henry Taupin; Kerry J Flom; Isabelle Tabah-Fisch; Giovanni Pauletti; Mary-Ann Lindsay; Alessandro Riva; Dennis J Slamon
Journal:  J Clin Oncol       Date:  2010-12-28       Impact factor: 44.544

2.  Combined detection of Her2/neu gene amplification and protein overexpression in effusions from patients with breast and ovarian cancer.

Authors:  Birgitta Schlüter; Roswitha Gerhards; Dirk Strumberg; Rudolf Voigtmann
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-09       Impact factor: 4.553

Review 3.  Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response.

Authors:  Monica M Reinholz; Amy K Bruzek; Daniel W Visscher; Wilma L Lingle; Matthew J Schroeder; Edith A Perez; Robert B Jenkins
Journal:  Lancet Oncol       Date:  2009-03       Impact factor: 41.316

4.  Her-2 neu (Cerb-B2) expression in fine needle aspiration samples of breast carcinoma: A pilot study comparing FISH, CISH and immunocytochemistry.

Authors:  Kusum Kapila; S Al-Awadhi; Im Francis
Journal:  J Cytol       Date:  2011-04       Impact factor: 1.000

Review 5.  Diagnostic value of fine-needle aspiration biopsy for breast mass: a systematic review and meta-analysis.

Authors:  Ying-Hua Yu; Wei Wei; Jian-Lun Liu
Journal:  BMC Cancer       Date:  2012-01-25       Impact factor: 4.430

6.  Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.

Authors:  A S Betof; Z N Rabbani; M E Hardee; S J Kim; G Broadwater; R C Bentley; S A Snyder; Z Vujaskovic; E Oosterwijk; L N Harris; J K Horton; M W Dewhirst; K L Blackwell
Journal:  Br J Cancer       Date:  2012-02-14       Impact factor: 7.640

7.  TOP2A gene copy number change in breast cancer.

Authors:  M J Engstrøm; B Ytterhus; L J Vatten; S Opdahl; A M Bofin
Journal:  J Clin Pathol       Date:  2014-01-08       Impact factor: 3.411

8.  Identification of Common Genes Refers to Colorectal Carcinogenesis with Paired Cancer and Noncancer Samples.

Authors:  Lihua Zhang; Yonglong Yang; Lin Cheng; Yu Cheng; Hong-Hao Zhou; Zhi-Rong Tan
Journal:  Dis Markers       Date:  2018-01-30       Impact factor: 3.434

9.  Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.

Authors:  Chang Yu; Fuqiang Chen; Jianjun Jiang; Hong Zhang; Meijuan Zhou
Journal:  Mol Med Rep       Date:  2019-06-04       Impact factor: 2.952

10.  Identification of Core Gene Expression Signature and Key Pathways in Colorectal Cancer.

Authors:  Xiang Ding; Houyu Duan; Hesheng Luo
Journal:  Front Genet       Date:  2020-02-21       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.